July 18, 2019 9:03am

What’s to report – nada, just another trading day!

Bottoms keep appearing, pricing growth appears and then disappears

Quarterly results haven’t even started to tabulate of my forty-five (45)

It's a daunting task to understand risk, seeing the unforeseen; on the basis of my own rules of reliability, I set-up my own “warning analysis” which isn’t machine oriented!  

 

Sustainability remains a cause for concern

 

Dow futures are DOWN -0.14% (-37 points), S&P futures are DOWN -0.05% (-2 points) and NASDAQ futures are also DOWN -0.04% (-13 points)

 

U.S. stock index futures were slightly lower Thursday morning as earnings season gathers momentum;

European markets slip with the pan-European Stoxx 600 slipping -0.4% by mid-morning;

Asia Pacific markets dipped with Japanese stocks the biggest losers amid renewed threats to any trade deal;

 

Henry’omics:

Markets closed Wednesday at a lows, trade negotiations between the U.S. and China had faltered over restrictions on Chinese telecommunications giant Huawei, citing sources familiar with the talks <CNBC>.

Is the sector about to regain momentum – it’s time in marginal increments!

Organovo (ONVO) adds to the reporting date (Q1) on 8/8.

From Wednesday’s evening post, “lucky, lucky the sector rose. Markets fell on Wednesday as the corporate earnings season rolled on. Volume was low and the Advance/decline (A/D0 line was strapped at 23/20 with 0 flat and 2 acquired.”

  • The NASDAQ was down -37.59 or -0.46% to 8,185.21;
  • The range of the 23 upside was +0.12% (BMRN) to +17.92% (CUR after a 1 for 20 reverse +$0.0632) while the 20 downside ranged from -0.15% (VCEL) to -4.49% (ONVO);
  • the IBB closed up +0.19% while the XBI closed up +0.05%’
  • 5 out of the 23 upside had higher than the 3 month average volume;
  • 1 out of the 20 downside had higher than the 3 month average volume;
  • Q3/19 so far: there were 4 positive, 1 holiday and 8 negative closes;

 

Companies in my headlights – It’s your decision; I provide an idea and context:

Oversold versus overbought pick one, it fits today and will change by tomorrow

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.